RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Regulatory Agency Hub

WHO Updates

The latest guidances, approvals, and safety alerts from WHO, curated by automated regulatory intelligence.

REGULATORY UPDATE
Invitation to a Webinar on managing reportable changes
WHO • Published: Nov 16, 2026

Webinar invitation focusing on how to manage reportable changes, implying expectations for structured change assessment and timely regulatory communication.

manufacturing
quality
+3
View update →
REGULATORY UPDATE
WHO Prequalifies Two STANDARD Q Malaria Rapid Diagnostic Tests
WHO • Published: Nov 16, 2026

WHO has added two STANDARD Q malaria rapid diagnostic tests to its list of prequalified in vitro diagnostic (IVD) products, enabling greater access and…

infectious_disease
manufacturing
+4
View update →
REGULATORY UPDATE
VCP Updates - October 2026
WHO • Published: Nov 16, 2026

Establishes a WHO public consultation process (until 30 October 2026) for a new Quality Assurance Mechanism pilot covering independent WHO assessment of…

infectious_disease
View update →
REGULATORY UPDATE
In Vitro Diagnostics Assessment Sessions for 2027
WHO • Published: Nov 16, 2026

Schedules WHO prequalification In Vitro Diagnostics Assessment Sessions across multiple 2027 date windows, enabling applicants to plan submission and…

infectious_disease
oncology
+16
View update →
REGULATORY UPDATE
New WHO Emergency Use Listing for Ebola diagnostics
WHO • Published: Nov 16, 2026

Lists the RADIONE Ebola Detection Kit under WHO’s Emergency Use Listing (EUL), increasing the availability of quality-assured Ebola molecular diagnostics for…

infectious_disease
manufacturing
+4
View update →
REGULATORY UPDATE
WHO adds BioFire® Global Fever Special Pathogens Panel to EUL
WHO • Published: Nov 16, 2026

Adds the BioFire® Global Fever Special Pathogens Panel to WHO’s Emergency Use Listing (EUL), expanding availability of a quality-assured multiplex diagnostic…

infectious_disease
manufacturing
+4
View update →
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
WHO • Published: Nov 16, 2026

WHO prequalifies the dolutegravir (sodium) active pharmaceutical ingredient (API) manufactured by Micro Labs Limited, enabling finished pharmaceutical product…

infectious_disease
manufacturing
+1
View update →
REGULATORY UPDATE
44th invitation for expressions of interest for API Prequalification announced
WHO • Published: Nov 16, 2026

Launches a 44th WHO Prequalification Programme invitation requesting expressions of interest (EOIs) from API manufacturers to support WHO evaluation and…

manufacturing
quality
View update →
REGULATORY UPDATE
WHO publishes first acknowledged lists of contraceptive products
WHO • Published: Nov 16, 2026

Acknowledges WHO prequalification lists for UNFPA-prequalified male latex condoms and TCu380A IUDs, signaling the transition of related prequalification…

manufacturing
quality
+3
View update →
REGULATORY UPDATE
WHO PQT launches eCTD submissions through the ePQS Portal
WHO • Published: Nov 16, 2026

Launches eCTD submission capability for WHO PQT via the ePQS Portal, enabling more standardized electronic regulatory dossiers and potentially smoother…

View update →
REGULATORY UPDATE
2026 Joint UNICEF, UNFPA and WHO Meeting with Manufacturers and Suppliers
WHO • Published: Nov 16, 2026

Convenes a hybrid (in-person/virtual) 2026 global meeting for manufacturers and suppliers of health products to exchange experience, discuss emerging…

manufacturing
quality
+2
View update →
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
WHO • Published: Nov 16, 2026

WHO prequalifies tenofovir disoproxil fumarate manufactured by Viyash Scientific Limited under the WHO API prequalification procedure.

infectious_disease
manufacturing
+1
View update →
REGULATORY UPDATE
Update on Nitrosamine Impurities
WHO • Published: Nov 16, 2026

Recognizes and operationalizes the ICH M7 (R2) less-than-lifetime (LTL) approach for nitrosamine impurity acceptable intakes for eligible short treatment…

quality
safety
+3
View update →
SAFETY ALERT
10th Invitation to Manufacturers of Medicinal Products for Treatment of Neglected Tropical Diseases to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
WHO • Published: Nov 16, 2026

Expands WHO Prequalification Unit product-evaluation engagement by updating the manufacturer invitation/EOI process and adding Acoziborole 320 mg tablets for…

infectious_disease
manufacturing
+4
View update →
REGULATORY UPDATE
First Insulin Glargine biosimilar product prequalified
WHO • Published: Nov 16, 2026

Adds insulin glargine biosimilar BT-DM007 to the WHO prequalified list, marking the first such biosimilar approved through the abridged WHO prequalification…

manufacturing
quality
+4
View update →
REGULATORY UPDATE
Macleods’s Primaquine pediatric products prequalified
WHO • Published: Nov 16, 2026

Adds Macleods’s primaquine pediatric tablet strengths (2.5 mg, 5 mg, 7.5 mg) for Plasmodium vivax and Plasmodium ovale relapse prevention to the WHO…

infectious_disease
pediatrics
View update →
SAFETY ALERT
11th Invitation to Manufacturers of Reproductive Health Products to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
WHO • Published: Nov 16, 2026

Invites manufacturers of listed reproductive health medicines to submit an Expression of Interest (EOI) to the WHO Prequalification Unit for product…

cardiology
hematology
+5
View update →
REGULATORY UPDATE
Cipla’s Nirmatrelvir + Ritonavir and Getz’s Moxifloxacin tablet products prequalified
WHO • Published: Nov 16, 2026

Adds two new WHO Prequalification (PQT) entries to the prequalified list: Cipla’s nirmatrelvir/ritonavir co-blistered tablets for higher-risk non-severe…

infectious_disease
respiratory
+5
View update →
SAFETY ALERT
New Deadline for Submission: Request for Quotations (RFQ) from interested Notified Bodies - WHO Prequalification Assessment for Medical Devices
WHO • Published: Nov 10, 2026

Requests for Quotations (RFQs) have been extended to 10 October 2026 to recruit European Notified Bodies to expand WHO’s capacity for technical documentation…

manufacturing
quality
+5
View update →
REGULATORY UPDATE
PQT/AMD newsletter - Q3 2026, Issue 54 is now available
WHO • Published: Nov 10, 2026

Announces availability of the WHO PQT/AMD newsletter issue covering recent updates and activities related to the AMD program area.

View update →

Get WHO alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.